{
    "nctId": "NCT00312429",
    "officialTitle": "Cord Blood Transplantation in Adult Recipients",
    "inclusionCriteria": "* Diagnosis reviewed at transplant center and confirmed to fit the criterion for high risk blood disease or cancer, as defined for the study\n* Estimated life expectancy of at least 6 weeks following study entry\n* Cancer and Leukemia Group B (CALGB) performance status less than or equal to 2\n* White blood cell count, platelet, hematocrit, tuberculosis, aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase, creatinine, and HIV test results reviewed by transplant center\n* Multiple gated acquisition (MUGA), echocardiogram, cardiac MRI, and/or pulmonary function tests (PFT) performed and reviewed by transplant center (for individuals with an ejection fraction and diffusing capacity \\[DLCO\\] of 40-50%, the appropriate cardiology or pulmonary consultations should be considered if the individual has severe heart or lung disease at the initiation of therapy)\n* Sufficient number of umbilical cord blood units available for transplantation\n* If female, willing to use contraception throughout the study\n* Must have minimum age of 18 Years\n* Must have maximum age of 70 Years",
    "exclusionCriteria": "* Undergoing Interleukin-2 (IL-2) therapy within 8 weeks of study entry\n* Diagnosed with a medical or psychiatric illness that may interfere with study participation\n* Pregnant"
}